EUVIMEDEUVIMED entdecken
Crossref

The Fusion Protein MuSK ‐Fc Functions as a Decoy to Block the Binding of Anti‐ MuSK Antibodies to MuSK

Akiyuki Uzawa iD, Hiroyuki Akamine, Manato Yasuda iD, Hideo Handa, Etsuko Ogaya, Kentaro Kurumada, Yosuke Onishi, Satoshi Kuwabara iD

Scandinavian Journal of Immunology · 2025

DOI: 10.1111/sji.70033 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Scandinavian Journal of Immunology, 2025. Verfasst von Akiyuki Uzawa und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Graduate School of Medicine, Chiba University, Japan. Hauptthemen laut MEDLINE: Myasthenia Gravis, Autoantibodies, Immunoglobulin Fc Fragments, Receptors, Cholinergic. Die Arbeit nennt 16 Literaturangaben. Gefördert von: Ministry of Education, Science and Technology, Ministry of Health, Labour and Welfare.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Muscle‐specific tyrosine kinase antibody‐positive myasthenia gravis (MuSKMG) is a rare subtype of MG that is often more refractory to immune treatment than acetylcholine receptor (AChR) antibody‐positive MG. Therefore, novel therapeutic strategies are needed. We previously developed AChR‐Fc, an Fc fusion protein that neutralises pathogenic autoantibodies and suppresses pathogenic B cells while preserving normal immunity, as a potential treatment for AChR antibody‐positive MG. Subsequently, we conducted preliminary experiments on MuSK‐Fc, a fusion protein targeting MuSKMG, using patient serum samples. This study examined whether MuSK‐Fc binds to MuSK antibodies and inhibits MuSK antibody binding to MuSK. We found that MuSK‐Fc specifically binds to MuSK antibodies and prevents their interaction with MuSK. These findings indicate that MuSK‐Fc may neutralise pathogenic antibodies and suppress disease activity in MuSKMG.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myasthenia GravisAutoantibodiesImmunoglobulin Fc FragmentsReceptors, CholinergicReceptor Protein-Tyrosine KinasesHumansMaleFemaleAdultMiddle AgedAgedRecombinant Fusion Proteins

Stichwörter der Autor:innen

fusion proteinmuscle‐specific tyrosine kinasemyasthenia gravisneutralisationnovel treatment

Substanzen

myasthenia gravis anti-skeletal muscle antibodyAutoantibodiesImmunoglobulin Fc FragmentsMUSK protein, humanReceptors, CholinergicReceptor Protein-Tyrosine KinasesRecombinant Fusion Proteins

Autor:innen und Institutionen

  • Department of Neurology, Graduate School of Medicine, Chiba University, Japan.
  • Department of Cardiovascular Medicine, Nephrology, and Neurology, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan.
  • Research Institute of Disaster Medicine, Chiba University, Japan.

ORCID-Profile: Akiyuki Uzawa, Manato Yasuda, Satoshi Kuwabara

Förderung

  • Ministry of Education, Science and Technology
  • Ministry of Health, Labour and Welfare

Zitieren

APA

Uzawa, A., Akamine, H., Yasuda, M., Handa, H., Ogaya, E., Kurumada, K., Onishi, Y., & Kuwabara, S. (2025). The Fusion Protein MuSK ‐Fc Functions as a Decoy to Block the Binding of Anti‐ MuSK Antibodies to MuSK. Scandinavian Journal of Immunology. https://doi.org/10.1111/sji.70033

Vancouver

Uzawa A, Akamine H, Yasuda M, Handa H, Ogaya E, Kurumada K, et al. The Fusion Protein MuSK ‐Fc Functions as a Decoy to Block the Binding of Anti‐ MuSK Antibodies to MuSK. Scandinavian Journal of Immunology. 2025. doi:10.1111/sji.70033

BibTeX
@article{Uzawa2025,
  author = {Uzawa, Akiyuki and Akamine, Hiroyuki and Yasuda, Manato and Handa, Hideo and Ogaya, Etsuko and Kurumada, Kentaro and Onishi, Yosuke and Kuwabara, Satoshi},
  title = {The Fusion Protein MuSK ‐Fc Functions as a Decoy to Block the Binding of Anti‐ MuSK Antibodies to MuSK},
  journal = {Scandinavian Journal of Immunology},
  year = {2025},
  doi = {10.1111/sji.70033}
}
Kostenlos starten →